Karachi Center Hosts Closing Ceremony for Chinese Medicine Trial
The closing ceremony for a Chinese medicine clinical trial took place simultaneously in China and at the Center for Bioequivalence … Read More The post Karachi Center Hosts Closing Ceremony for Chinese Medicine Trial appeared first on ProPakistani .
A closing ceremony for a Chinese medicine clinical trial unfolded simultaneously in China and at the University of Karachi's Center for Bioequivalence Studies and Clinical Research (CBSCR). The Panjwani Center for Molecular Medicine and Drug Research (PCMD) spearheaded the study, which evaluated the effectiveness and safety of Jinhua Qinggan Granules (JHQG) in treating acute upper respiratory tract infection (AURI).
The primary objective was to provide data supporting JHQG's registration. Prof. Dr. Muhammad Raza Shah, Director of ICCBS, highlighted the crucial role of clinical trials in advancing public health. The randomized, double-blind, placebo-controlled design was employed to assess JHQG's efficacy in AURI patients. This trial exemplifies the collaborative medical research efforts between Pakistan and China, with a shared goal of promoting evidence-based treatment options and drug development.
Written by urgent.news from ProPakistani's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
